ANI Pharmaceuticals (ANIP) News Today $57.79 +0.52 (+0.91%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$57.77 -0.02 (-0.03%) As of 05/23/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs PeersMay 23 at 8:02 AM | msn.comANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout FlaresMay 22 at 7:23 AM | finance.yahoo.comANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout FlaresMay 22 at 7:00 AM | globenewswire.comSoleus Capital Management L.P. Has $11.35 Million Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Soleus Capital Management L.P. lowered its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 23.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 205,294 shares of the specialty pharmaMay 21 at 8:13 AM | marketbeat.comStonepine Capital Management LLC Makes New Investment in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Stonepine Capital Management LLC bought a new position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 20,400 shares of the specialty pharmaceuMay 20, 2025 | marketbeat.comTang Capital Management LLC Lowers Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Tang Capital Management LLC decreased its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 29.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 317,500 shares of the specialty pharmacMay 20, 2025 | marketbeat.comAmeriprise Financial Inc. Raises Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Ameriprise Financial Inc. increased its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 14.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 271,805 shares of the specialty pharmaceutical company's stock aftMay 20, 2025 | marketbeat.comMillennium Management LLC Has $55.44 Million Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Millennium Management LLC raised its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 89.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,002,849 shares of the specialty pharmaceutical coMay 19, 2025 | marketbeat.com6,358 Shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Acquired by Graham Capital Management L.P.Graham Capital Management L.P. bought a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 6,358 shares of the specialty pharmaceutical company's stock, valMay 19, 2025 | marketbeat.comNorthern Trust Corp Raises Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Northern Trust Corp raised its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 9.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 204,345 shares of the specialty pharmaceutical coMay 19, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) SVP Ori Gutwerg Sells 881 SharesMay 17, 2025 | insidertrades.comD. E. Shaw & Co. Inc. Boosts Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)D. E. Shaw & Co. Inc. boosted its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 80.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 196,319 shares of the specialty pharmaceutical compMay 17, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Insider Sells $241,800.00 in StockMay 16, 2025 | insidertrades.com38,488 Shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Acquired by Balyasny Asset Management L.P.Balyasny Asset Management L.P. bought a new position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 38,488 shares of the specialty pharmaceutical comMay 15, 2025 | marketbeat.comComerica Bank Sells 8,099 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Comerica Bank lowered its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 30.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,830 shares of the specialty pharmaceuticalMay 15, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Earns "Buy" Rating from GuggenheimGuggenheim reiterated a "buy" rating and issued a $86.00 price target on shares of ANI Pharmaceuticals in a research report on Monday.May 14, 2025 | marketbeat.comGuggenheim Reiterates Buy Rating for ANI Pharmaceuticals (NASDAQ:ANIP)May 14, 2025 | americanbankingnews.comANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQMay 12, 2025 | globenewswire.comTower Research Capital LLC TRC Lowers Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Tower Research Capital LLC TRC lessened its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 74.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,547 shares of the specialty pharmaceutical company's stMay 12, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Sets New 52-Week High Following Strong EarningsANI Pharmaceuticals (NASDAQ:ANIP) Reaches New 12-Month High Following Earnings BeatMay 12, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Issues FY 2025 Earnings GuidanceANI Pharmaceuticals (NASDAQ:ANIP) updated its FY 2025 earnings guidance. The company provided EPS guidance of 6.270-6.620 for the period, compared to the consensus estimate of 6.340. The company also issued revenue guidance of $768.0 millionillion-$793.0 millionillion, compared to the consensus estimate of $769.6 millionillion.May 11, 2025 | marketbeat.comBridgefront Capital LLC Makes New Investment in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Bridgefront Capital LLC purchased a new stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,692 shares of the specialty pharmaceutical companMay 11, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comAn Overview of ANI Pharmaceuticals's EarningsMay 9, 2025 | benzinga.comANI Pharma Reports Upbeat Q1 Earnings, Revises Full-Year Outlook: Retail’s PleasedMay 9, 2025 | msn.comANI Pharmaceuticals (NASDAQ:ANIP) Reports Strong Q1, Full-Year Outlook Slightly Exceeds ExpectationsMay 9, 2025 | finance.yahoo.comANI Pharmaceuticals, Inc. (ANIP) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comDeep Track Capital LP Raises Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Deep Track Capital LP boosted its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 28.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 649,042 shares of the specialty pharmaceutical company's stocMay 9, 2025 | marketbeat.comANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 GuidanceMay 9, 2025 | globenewswire.comEarnings To Watch: ANI Pharmaceuticals (ANIP) Reports Q1 Results TomorrowMay 8, 2025 | finance.yahoo.comState of Tennessee Department of Treasury Sells 4,414 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)State of Tennessee Department of Treasury lowered its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 54.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,730 shares of the specialty phaMay 8, 2025 | marketbeat.comFirst Trust Advisors LP Has $1.80 Million Stock Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)First Trust Advisors LP cut its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 13.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,531 shares of the specialty pharmaceuMay 8, 2025 | marketbeat.comFreestone Grove Partners LP Takes $259,000 Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Freestone Grove Partners LP acquired a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 4,679 shares of the specialty pharmaceutical company's stock, valued at apMay 7, 2025 | marketbeat.comDimensional Fund Advisors LP Raises Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Dimensional Fund Advisors LP raised its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 4.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 685,730 shares of thMay 7, 2025 | marketbeat.comANI Pharmaceuticals: A Short-Term Buying OpportunityMay 6, 2025 | seekingalpha.comANI Pharmaceuticals (NASDAQ:ANIP) Hits New 52-Week High - What's Next?ANI Pharmaceuticals (NASDAQ:ANIP) Sets New 12-Month High - Should You Buy?May 5, 2025 | marketbeat.comANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse ModelMay 5, 2025 | globenewswire.comAquatic Capital Management LLC Purchases 4,040 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Aquatic Capital Management LLC lifted its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 149.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,740 shares of the speciaMay 5, 2025 | marketbeat.comANI Pharmaceuticals (ANIP) Projected to Post Earnings on FridayANI Pharmaceuticals (NASDAQ:ANIP) will be releasing its Q1 2025 earnings before the market opens on Friday, May 9. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-9-ani-pharmaceuticals-inc-stock/)May 4, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Recommendation of "Buy" by BrokeragesANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) has been given a consensus rating of "Buy" by the nine research firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has given a stMay 3, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Sees Large Volume Increase - Still a Buy?ANI Pharmaceuticals (NASDAQ:ANIP) Sees Unusually-High Trading Volume - Still a Buy?April 30, 2025 | marketbeat.comRaymond James Financial Inc. Invests $3.92 Million in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Raymond James Financial Inc. bought a new position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 70,826 shares of the specialty pharmaceuApril 29, 2025 | marketbeat.comGeneric Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The RestApril 28, 2025 | msn.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Bought by Oberweis Asset Management Inc.Oberweis Asset Management Inc. lifted its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 50.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 65,600 shares of the specialty phaApril 27, 2025 | marketbeat.comCanada Pension Plan Investment Board Buys New Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Canada Pension Plan Investment Board bought a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 30,700 shares of the specialty pharmaceutical company's stocApril 26, 2025 | marketbeat.comBarclays PLC Boosts Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Barclays PLC boosted its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 9.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 157,060 shares of the specialty pharmaceutical company's stock after buApril 26, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Cut to Sell at StockNews.comStockNews.com downgraded ANI Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Thursday.April 26, 2025 | marketbeat.comInvesco Ltd. Cuts Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)Invesco Ltd. lessened its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 10.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 197,545 shares of the specialty pharmaceutical company's stoApril 25, 2025 | marketbeat.comTruist Financial Issues Positive Forecast for ANI Pharmaceuticals (NASDAQ:ANIP) Stock PriceTruist Financial upped their price target on shares of ANI Pharmaceuticals from $62.00 to $65.00 and gave the company a "hold" rating in a research report on Monday.April 23, 2025 | marketbeat.comANI Pharmaceuticals price target raised to $65 from $62 at TruistApril 22, 2025 | markets.businessinsider.com Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Email Address ANIP Media Mentions By Week ANIP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIP News Sentiment▼1.270.75▲Average Medical News Sentiment ANIP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIP Articles This Week▼106▲ANIP Articles Average Week Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADMA Biologics News Vaxcyte News Rhythm Pharmaceuticals News Krystal Biotech News Sarepta Therapeutics News PTC Therapeutics News ACADIA Pharmaceuticals News Cytokinetics News Avidity Biosciences News Zai Lab News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIP) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Hidden Energy Source Backed by Billionaires Why Billionaires Have Set Their Sights on the Utah Desert Something strange is happening near the Wah Wah ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANIP Stock Free ANIP Stock Alerts